SkinHealth Systems (SKIN) Depreciation & Amortization (CF) (2020 - 2026)

SkinHealth Systems (SKIN) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $563000.0 in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $563000.0, down 69.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (down 71.68% YoY), and the FY2025 annual result was $3.8 million, down 61.29% from the prior year.
• Depreciation & Amortization (CF) slipped to $563000.0 in Q1 2026 per SKIN's latest filing, from $644000.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $4.3 million in Q4 2023 and troughed at $563000.0 in Q1 2026.
• A 5-year average of $1.9 million and a median of $1.9 million in 2025 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 154.4% in 2022, then tumbled 79.15% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $1.9 million in 2022, then surged by 128.81% to $4.3 million in 2023, then plunged by 66.47% to $1.5 million in 2024, then tumbled by 55.71% to $644000.0 in 2025, then decreased by 12.58% to $563000.0 in 2026.
• Business Quant data shows SKIN's Depreciation & Amortization (CF) at $563000.0 in Q1 2026, $644000.0 in Q4 2025, and $637000.0 in Q3 2025.